Evidence map›Paper›PMID 41944291›Full record

ArticleeLife2026

Separating selection from mutation in antibody language models.

Frederick A Matsen, Will Dumm, Kevin Sung, Mackenzie M Johnson, David H Rich, Tyler N Starr, Yun S Song, Julia Fukuyama, Hugh K Haddox

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Frederick A MatsenComputational Biology Program, Fred Hutchinson Cancer Center, Seattle, United States.ORCID https://orcid.org/0000-0003-0607-6025
Will DummComputational Biology Program, Fred Hutchinson Cancer Center, Seattle, United States.ORCID https://orcid.org/0000-0002-8617-476X
Kevin SungComputational Biology Program, Fred Hutchinson Cancer Center, Seattle, United States.ORCID https://orcid.org/0000-0002-7289-845X
Mackenzie M JohnsonComputational Biology Program, Fred Hutchinson Cancer Center, Seattle, United States.ORCID https://orcid.org/0000-0002-3915-2023
David H RichComputational Biology Program, Fred Hutchinson Cancer Center, Seattle, United States.
Tyler N StarrDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, United States.ORCID https://orcid.org/0000-0001-6713-6904
Yun S SongComputer Science Division and Department of Statistics, University of California, Berkeley, Berkeley, United States.ORCID https://orcid.org/0000-0002-0734-9868
Julia FukuyamaDepartment of Statistics, Indiana University, Bloomington, United States.ORCID https://orcid.org/0000-0002-7590-5563
Hugh K HaddoxComputational Biology Program, Fred Hutchinson Cancer Center, Seattle, United States.ORCID https://orcid.org/0000-0001-8324-8324

Funding

Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptorsR01AI146028 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MATSEN, FREDERICK ALBERT · 2019 to 2024
$3.4M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
The evolutionary landscape of HIV broadly neutralizing antibody developmentDP2AI177890 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Tyler Nelson Starr · 2023 to 2026
$1.8M
Scalable Computational Methods for Genealogical Inference: from species level to single cellsR01HG013117 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI Ian H Holmes, RASMUS NIELSEN · 2024 to 2026
$1.7M
Scalable Computational Methods for Genealogical Inference: from species level to single cellsR56HG013117 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI HOLMES, IAN H, NIELSEN, RASMUS · 2023 to 2023
$315k
NHGRI NIH HHS R01 HG013117NHGRI NIH HHS R56 HG013117NIAID NIH HHS DP2 AI177890NIAID NIH HHS R01 AI146028NIH HHS DP2-AI177890NIH HHS R01-AI146028NIH HHS R01-HG013117NIH HHS R56-HG013117NIH HHS S10 OD028685NIH HHS S10OD028685
6 · The paper itself

Abstract

Antibodies are encoded by nucleotide sequences that are generated by V(D)J recombination and evolve according to mutation and selection processes. Existing antibody language models, however, focus exclusively on antibodies as strings of amino acids and are fitted using standard language modeling objectives such as masked or autoregressive prediction. In this paper, we first show that fitting models using this objective implicitly incorporates nucleotide-level mutation processes as part of the protein language model, which degrades performance when predicting effects of mutations on functional properties of antibodies. To address this limitation, we devise a new framework: a deep amino acid selection model (DASM) that learns the selection effects of amino acid mutations while explicitly factoring out the nucleotide-level mutation process. By fitting selection as a separate term from the mutation process, the DASM exclusively quantifies functional effects: effects that change some aspect of the function of the antibody. This factorization leads to substantially improved performance on standard functional benchmarks. Moreover, our model is an order of magnitude smaller and multiple orders of magnitude faster to evaluate than existing approaches, as well as being readily interpretable.

Indexed as

AntibodiesMutationSelection, GeneticHumansAntibodiesaffinity maturationantibody engineeringantibody language modelevolutionary biologyfunctional predictionhumanimmunologyinflammationmutation-selection modelsomatic hypermutation

Identifiers

PMID41944291
PMCPMC13056363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.